Gosset BioChip Labs General Information
BioChip Labs offers CLIA-certified laboratory testing specializing in blood disorders such as sickle cell disease and thalassemia. The company is developing a proprietary microfluidic device ("Endothelium-on-a-chip") with machine learning automation to enable efficient drug screening and a nanoparticle-based system to simplify the manufacturing of biologics by directly purifying monoclonal antibodies from cell culture. Their technology aims to reduce costs, improve yields, and enable mass commercialization of advanced therapies like gene therapy[1][2][3][5].
Contact Information
USA
Drug Pipeline
No pipeline data available
Key Partnerships
Cleveland Clinic’s Global Cardiovascular Innovations Center—BioChip Labs is the only outside biotech company invited into this incubator program[1][5]
BioChip Labs Funding
No funding data available